AI assistant
DEVRO PLC Earnings Release 2021
4717_er_2022-01-19_90a74713-6b10-4318-ba5a-1560a37e4057.html
Earnings Release
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 8735Y
Devro PLC
19 January 2022
19 January 2022
Devro plc
Trading update
Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the year ended 31 December 2021.
Revenue growth for the full year was encouraging with positive developments in volume, price and mix resulting in strong performances in both mature and emerging markets. 2021 constant currency revenue growth was circa 5%.
We anticipate 2021 operating profit performance to be in line with expectations, representing in excess of 10% constant currency growth, with earnings per share modestly ahead of current analyst expectations* due to a one-off tax benefit arising from the change in the UK corporate tax rate.
The Group also delivered strong cash generation in the final quarter. Net debt at the end of December 2021 was £90 million with net debt/EBITDA at circa 1.4x.
Devro will announce its results for the year ended 31 December 2021 on 2 March 2022.
*Company compiled consensus 2021 earnings per share average - 16.9p
ENDS
Contacts:
Devro plc
| Rutger Helbing | Chief Executive Officer | Tel: 020 3865 7637 |
| Rohan Cummings | Chief Financial Officer | Tel: 020 3865 7637 |
FTI Consulting
| Richard Mountain | Tel: 020 3727 1340 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTSFWFWAEESELF